Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma

Minoru Kanke, Masato Fujii, Kaori Kameyama, Jin Kanzaki, Yutaha Tokumaru, Yorihisa Imanishi, Toshihi Tomita, Yasuhiro Matsumura

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Objectives: To determine the correlation between the expression of CD44 variant exon 6 (v6) and the clinicopathological features of head and neck squamous cell carcinomas (HNSCCs), and to study the role of CD44v6 in cell invasion using a human HNSCC cell line (HSC-2). Design: The expression of CD44v6 was evaluated using immunohistochemical analysis in paraffin-embedded tissue specimens from 89 primary lesions. The concentration of CD44v6 protein in 37 cryopreserved tumor specimens was evaluated using the enzyme-linked immunosorbent assay. The HSC-2 cells were treated with 2F10, a monoclonal antibody against CD44v6. The effects of 2F10 on HSC-2 cell proliferation, migration, and invasion potential were evaluated. Results: The down-regulation of CD44v6 expression or the concentration of cancer tissue significantly correlated with a lower degree of pathohistological differentiation and a higher rate of cervical metastasis. The invasion of HSC-2 cells into type I collagen gel and the expression of CD44v6 were decreased in invading cells released from the upper layer. Furthermore, the treatment of HSC-2 cells with 2F10 significantly enhanced cell invasion. However, 2F10 did not affect either the proliferation or migration properties of HSC-2 cells. Conclusions: The down-regulation of CD44v6 expression may be useful as a biological marker for the degree of malignancy in HNSCCs. We assume that the loss or dysfunction of CD44v6 is involved in the acquisition of invasion ability in HSC-2 cells. In addition, the potential existence of a CD44v6-mediated signal transduction pathway may play a role in inhibiting the invasion in HNSCCs.

Original languageEnglish
Pages (from-to)1217-1223
Number of pages7
JournalArchives of Otolaryngology - Head and Neck Surgery
Volume126
Issue number10
Publication statusPublished - 2000

Fingerprint

Exons
Down-Regulation
Neoplasms
Carcinoma, squamous cell of head and neck
Collagen Type I
Paraffin
Cell Movement
Signal Transduction
Biomarkers
Gels
Enzyme-Linked Immunosorbent Assay
Monoclonal Antibodies
Cell Proliferation
Neoplasm Metastasis
Cell Line
Proteins

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Kanke, M., Fujii, M., Kameyama, K., Kanzaki, J., Tokumaru, Y., Imanishi, Y., ... Matsumura, Y. (2000). Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma. Archives of Otolaryngology - Head and Neck Surgery, 126(10), 1217-1223.

Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma. / Kanke, Minoru; Fujii, Masato; Kameyama, Kaori; Kanzaki, Jin; Tokumaru, Yutaha; Imanishi, Yorihisa; Tomita, Toshihi; Matsumura, Yasuhiro.

In: Archives of Otolaryngology - Head and Neck Surgery, Vol. 126, No. 10, 2000, p. 1217-1223.

Research output: Contribution to journalArticle

Kanke, M, Fujii, M, Kameyama, K, Kanzaki, J, Tokumaru, Y, Imanishi, Y, Tomita, T & Matsumura, Y 2000, 'Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma', Archives of Otolaryngology - Head and Neck Surgery, vol. 126, no. 10, pp. 1217-1223.
Kanke, Minoru ; Fujii, Masato ; Kameyama, Kaori ; Kanzaki, Jin ; Tokumaru, Yutaha ; Imanishi, Yorihisa ; Tomita, Toshihi ; Matsumura, Yasuhiro. / Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma. In: Archives of Otolaryngology - Head and Neck Surgery. 2000 ; Vol. 126, No. 10. pp. 1217-1223.
@article{6267c0c74fd44954818340be32c208eb,
title = "Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma",
abstract = "Objectives: To determine the correlation between the expression of CD44 variant exon 6 (v6) and the clinicopathological features of head and neck squamous cell carcinomas (HNSCCs), and to study the role of CD44v6 in cell invasion using a human HNSCC cell line (HSC-2). Design: The expression of CD44v6 was evaluated using immunohistochemical analysis in paraffin-embedded tissue specimens from 89 primary lesions. The concentration of CD44v6 protein in 37 cryopreserved tumor specimens was evaluated using the enzyme-linked immunosorbent assay. The HSC-2 cells were treated with 2F10, a monoclonal antibody against CD44v6. The effects of 2F10 on HSC-2 cell proliferation, migration, and invasion potential were evaluated. Results: The down-regulation of CD44v6 expression or the concentration of cancer tissue significantly correlated with a lower degree of pathohistological differentiation and a higher rate of cervical metastasis. The invasion of HSC-2 cells into type I collagen gel and the expression of CD44v6 were decreased in invading cells released from the upper layer. Furthermore, the treatment of HSC-2 cells with 2F10 significantly enhanced cell invasion. However, 2F10 did not affect either the proliferation or migration properties of HSC-2 cells. Conclusions: The down-regulation of CD44v6 expression may be useful as a biological marker for the degree of malignancy in HNSCCs. We assume that the loss or dysfunction of CD44v6 is involved in the acquisition of invasion ability in HSC-2 cells. In addition, the potential existence of a CD44v6-mediated signal transduction pathway may play a role in inhibiting the invasion in HNSCCs.",
author = "Minoru Kanke and Masato Fujii and Kaori Kameyama and Jin Kanzaki and Yutaha Tokumaru and Yorihisa Imanishi and Toshihi Tomita and Yasuhiro Matsumura",
year = "2000",
language = "English",
volume = "126",
pages = "1217--1223",
journal = "JAMA Otolaryngology - Head and Neck Surgery",
issn = "2168-6181",
publisher = "American Medical Association",
number = "10",

}

TY - JOUR

T1 - Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma

AU - Kanke, Minoru

AU - Fujii, Masato

AU - Kameyama, Kaori

AU - Kanzaki, Jin

AU - Tokumaru, Yutaha

AU - Imanishi, Yorihisa

AU - Tomita, Toshihi

AU - Matsumura, Yasuhiro

PY - 2000

Y1 - 2000

N2 - Objectives: To determine the correlation between the expression of CD44 variant exon 6 (v6) and the clinicopathological features of head and neck squamous cell carcinomas (HNSCCs), and to study the role of CD44v6 in cell invasion using a human HNSCC cell line (HSC-2). Design: The expression of CD44v6 was evaluated using immunohistochemical analysis in paraffin-embedded tissue specimens from 89 primary lesions. The concentration of CD44v6 protein in 37 cryopreserved tumor specimens was evaluated using the enzyme-linked immunosorbent assay. The HSC-2 cells were treated with 2F10, a monoclonal antibody against CD44v6. The effects of 2F10 on HSC-2 cell proliferation, migration, and invasion potential were evaluated. Results: The down-regulation of CD44v6 expression or the concentration of cancer tissue significantly correlated with a lower degree of pathohistological differentiation and a higher rate of cervical metastasis. The invasion of HSC-2 cells into type I collagen gel and the expression of CD44v6 were decreased in invading cells released from the upper layer. Furthermore, the treatment of HSC-2 cells with 2F10 significantly enhanced cell invasion. However, 2F10 did not affect either the proliferation or migration properties of HSC-2 cells. Conclusions: The down-regulation of CD44v6 expression may be useful as a biological marker for the degree of malignancy in HNSCCs. We assume that the loss or dysfunction of CD44v6 is involved in the acquisition of invasion ability in HSC-2 cells. In addition, the potential existence of a CD44v6-mediated signal transduction pathway may play a role in inhibiting the invasion in HNSCCs.

AB - Objectives: To determine the correlation between the expression of CD44 variant exon 6 (v6) and the clinicopathological features of head and neck squamous cell carcinomas (HNSCCs), and to study the role of CD44v6 in cell invasion using a human HNSCC cell line (HSC-2). Design: The expression of CD44v6 was evaluated using immunohistochemical analysis in paraffin-embedded tissue specimens from 89 primary lesions. The concentration of CD44v6 protein in 37 cryopreserved tumor specimens was evaluated using the enzyme-linked immunosorbent assay. The HSC-2 cells were treated with 2F10, a monoclonal antibody against CD44v6. The effects of 2F10 on HSC-2 cell proliferation, migration, and invasion potential were evaluated. Results: The down-regulation of CD44v6 expression or the concentration of cancer tissue significantly correlated with a lower degree of pathohistological differentiation and a higher rate of cervical metastasis. The invasion of HSC-2 cells into type I collagen gel and the expression of CD44v6 were decreased in invading cells released from the upper layer. Furthermore, the treatment of HSC-2 cells with 2F10 significantly enhanced cell invasion. However, 2F10 did not affect either the proliferation or migration properties of HSC-2 cells. Conclusions: The down-regulation of CD44v6 expression may be useful as a biological marker for the degree of malignancy in HNSCCs. We assume that the loss or dysfunction of CD44v6 is involved in the acquisition of invasion ability in HSC-2 cells. In addition, the potential existence of a CD44v6-mediated signal transduction pathway may play a role in inhibiting the invasion in HNSCCs.

UR - http://www.scopus.com/inward/record.url?scp=0033772064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033772064&partnerID=8YFLogxK

M3 - Article

C2 - 11031408

AN - SCOPUS:0033772064

VL - 126

SP - 1217

EP - 1223

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 10

ER -